174 related articles for article (PubMed ID: 24489649)
1. Phenotyping of human melanoma cells reveals a unique composition of receptor targets and a subpopulation co-expressing ErbB4, EPO-R and NGF-R.
Mirkina I; Hadzijusufovic E; Krepler C; Mikula M; Mechtcheriakova D; Strommer S; Stella A; Jensen-Jarolim E; Höller C; Wacheck V; Pehamberger H; Valent P
PLoS One; 2014; 9(1):e84417. PubMed ID: 24489649
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin receptor contributes to melanoma cell survival in vivo.
Kumar SM; Zhang G; Bastian BC; Arcasoy MO; Karande P; Pushparajan A; Acs G; Xu X
Oncogene; 2012 Mar; 31(13):1649-60. PubMed ID: 21860424
[TBL] [Abstract][Full Text] [Related]
3. ErbB receptors mediate both migratory and proliferative activities in human melanocytes and melanoma cells.
Gordon-Thomson C; Jones J; Mason RS; Moore GP
Melanoma Res; 2005 Feb; 15(1):21-8. PubMed ID: 15714117
[TBL] [Abstract][Full Text] [Related]
4. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
Aguilar C; Aguilar C; Lopez-Marure R; Jiménez-Sánchez A; Rocha-Zavaleta L
Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629
[TBL] [Abstract][Full Text] [Related]
5. Coexpression of Kit and the receptors for erythropoietin, interleukin 6 and GM-CSF on hemopoietic cells.
de Jong MO; Westerman Y; Wagemaker G; Wognum AW
Stem Cells; 1997; 15(4):275-85. PubMed ID: 9253111
[TBL] [Abstract][Full Text] [Related]
6. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential.
Huang S; Luca M; Gutman M; McConkey DJ; Langley KE; Lyman SD; Bar-Eli M
Oncogene; 1996 Dec; 13(11):2339-47. PubMed ID: 8957075
[TBL] [Abstract][Full Text] [Related]
7. The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells.
Redmer T; Welte Y; Behrens D; Fichtner I; Przybilla D; Wruck W; Yaspo ML; Lehrach H; Schäfer R; Regenbrecht CR
PLoS One; 2014; 9(5):e92596. PubMed ID: 24799129
[TBL] [Abstract][Full Text] [Related]
8. Role of erythropoietin receptor expression in malignant melanoma.
Mirmohammadsadegh A; Marini A; Gustrau A; Delia D; Nambiar S; Hassan M; Hengge UR
J Invest Dermatol; 2010 Jan; 130(1):201-10. PubMed ID: 19536148
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.
Prickett TD; Agrawal NS; Wei X; Yates KE; Lin JC; Wunderlich JR; Cronin JC; Cruz P; Rosenberg SA; Samuels Y
Nat Genet; 2009 Oct; 41(10):1127-32. PubMed ID: 19718025
[TBL] [Abstract][Full Text] [Related]
10. A novel mechanism of cooperation between c-Kit and erythropoietin receptor. Stem cell factor induces the expression of Stat5 and erythropoietin receptor, resulting in efficient proliferation and survival by erythropoietin.
Kapur R; Zhang L
J Biol Chem; 2001 Jan; 276(2):1099-106. PubMed ID: 11042182
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a new human melanoma cell line with CD133 expression.
Gil-Benso R; Monteagudo C; Cerdá-Nicolás M; Callaghan RC; Pinto S; Martínez-Romero A; Pellín-Carcelén A; San-Miguel T; Cigudosa JC; López-Ginés C
Hum Cell; 2012 Jun; 25(2):61-7. PubMed ID: 22529031
[TBL] [Abstract][Full Text] [Related]
12. The absence of the ERBB4 hotspot mutations in melanomas in patients from southern China.
Zhou QM; Li W; Guan YX; Zhang X; Chen XC; Ding Y; Wen XZ; Peng RQ; Yan SM; Zhang XS
Chin J Cancer; 2013 Jul; 32(7):410-4. PubMed ID: 23237222
[TBL] [Abstract][Full Text] [Related]
13. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin activates the phosphoinositide 3-kinase/Akt pathway in human melanoma cells.
Kumar SM; Yu H; Fong D; Acs G; Xu X
Melanoma Res; 2006 Aug; 16(4):275-83. PubMed ID: 16845323
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibitors of c-KIT block mutant c-KIT mediated migration of melanocytes and melanoma cells in vitro and in vivo.
Posch C; Moslehi H; Sanlorenzo M; Green G; Vujic I; Panzer-Grümayer R; Rappersberger K; Ortiz-Urda S
Oncotarget; 2016 Jul; 7(29):45916-45925. PubMed ID: 27322141
[TBL] [Abstract][Full Text] [Related]
16. Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens.
Schadendorf D; Fichtner I; Makki A; Alijagic S; Küpper M; Mrowietz U; Henz BM
Br J Cancer; 1996 Jul; 74(2):194-9. PubMed ID: 8688321
[TBL] [Abstract][Full Text] [Related]
17. An ERBB3/ERBB2 oncogenic unit plays a key role in NRG1 signaling and melanoma cell growth and survival.
Zhang K; Wong P; Duan J; Jacobs B; Borden EC; Bedogni B
Pigment Cell Melanoma Res; 2013 May; 26(3):408-14. PubMed ID: 23480537
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin stimulates melanoma tumor growth through activation of initiation factor eIF4E.
Julius A; Desai A; Yung RL
Oncotarget; 2017 May; 8(18):30317-30327. PubMed ID: 28415825
[TBL] [Abstract][Full Text] [Related]
19. Nerve growth and expression of receptors for nerve growth factor in tumors of melanocyte origin.
Bröcker EB; Magiera H; Herlyn M
J Invest Dermatol; 1991 May; 96(5):662-5. PubMed ID: 1850772
[TBL] [Abstract][Full Text] [Related]
20. CD166high Uveal Melanoma Cells Represent a Subpopulation With Enhanced Migratory Capacity.
Djirackor L; Kalirai H; Coupland SE; Petrovski G
Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2696-2704. PubMed ID: 31242292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
